This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pacheco, D. Y. Articles by Gibson, N. W. Search for Related Content PubMed PubMed Citation Articles by Pacheco, D. Y. Articles by Gibson, N. W.

Comparison of the Mechanism of Action of Busulfan with Hepsulfam, a New Antileukemic Agent, in the L1210 Cell Line¹

Laboratory of Pharmacology, AMC Cancer Research Center, Denver, Colorado 80214 [D. Y. P., N. K. S., N. W. G.], and School of Pharmacy, University of Colorado, Boulder, Colorado 80309 [N. W. G.]

1,7-Heptanediol disulfamate (hepsulfam, NSC 329680) is a new antileukemic agent with close structural similarity to busulfan. The mechanism of action of hepsulfam is not known and it has recently been entered into Phase I clinical trials by the National Cancer Institute. Waud et al. have recently shown that hepsulfam has good antitumor activity against mouse L1210 leukemia in vivo (Waud et al., Proc. Am. Assoc. Cancer Res., 29: 333, 1988). In contrast, busulfan was inactive against this model tumor system. In the present study, we have compared the in vitro cytotoxicity of hepsulfam with that of busulfan and we also examined the ability of these compounds to induce DNA damage in the L1210 leukemia cell line. Our results show that L1210 leukemia cells were 7-fold more sensitive to hepsulfam than busulfan. Only hepsulfam produced an appreciable quantity of DNA interstrand cross-linking in L1210 cells, with the peak of cross-link formation being delayed 12 h following a 2-h drug treatment. In contrast, both compounds also produced DNA-protein cross-linking, again with the formation of peak levels being delayed 6–12 h after drug treatment. At equimolar concentrations, hepsulfam produced a greater quantity of DNA interstrand cross-links and DNA-protein cross-links than busulfan. In contrast, busulfan produced a greater quantity of DNA-protein cross-links, when compared to hepsulfam at equitoxic concentrations.

¹ This work was supported in part by a gift to A. M. C. by The Women's Event, St. Louis, MO.

² To whom requests for reprints should be addressed.

Received 11/28/88. Revised 3/ 2/89. Revised 5/22/89. Accepted 6/14/89.

This article has been cited by other articles:

				P. Morales-Ramirez, T. Vallarino-Kelly, V. L. Cruz-Vallejo, R. Lopez-Iturbe, and H. Alvaro-Delgadillo In vivo kinetics of micronuclei induction by bifunctional alkylating antineoplastics Mutagenesis, May 1, 2004; 19(3): 207 - 213. [Abstract] [Full Text] [PDF]

				G. R. Westerhof, R. E. Ploemacher, A. Boudewijn, I. Blokland, J. H. Dillingh, A. T. McGown, J. A. Hadfield, M. J. Dawson, and J. D. Down Comparison of Different Busulfan Analogues for Depletion of Hematopoietic Stem Cells and Promotion of Donor-Type Chimerism in Murine Bone Marrow Transplant Recipients Cancer Res., October 1, 2000; 60(19): 5470 - 5478. [Abstract] [Full Text]